Register for free
Recent Quotes
My Watchlist
Indicators
Business Insurance Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Pfizer (NY: PFE )

28.89 -0.20 (-0.67%)
Streaming Delayed Price Updated: 3:53 PM EDT, Sep 30, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 16,720,229
Open 29.11
Bid (Size) 28.89 (95)
Ask (Size) 28.90 (118)
Prev. Close 29.09
Today's Range 28.78 - 29.19
52wk Range 25.20 - 34.11
Shares Outstanding 5,606,688,356
Dividend Yield 5.68%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Top 3 Discounted Value Stocks Worth Buying Now
These stocks have a large cushion while retaining intrinsic value. 
Via Talk Markets
Optimism Around Aquestive As it Moves Forward With Severe Allergy, Baldness Candidate
Aquestive Therapeutics hosted a virtual investor day, announcing advancements in Anaphylm and AQST-108. The company aims for FDA meetings in late 2024, targeting a 2025 NDA submission, while HC... 
Via Benzinga
Exposures Product Safety

Performance

YTD
-2.81%
-2.81%
1 Month
-0.40%
-0.40%
3 Month
+2.39%
+2.39%
6 Month
+4.24%
+4.24%
1 Year
-14.86%
-14.86%

More News

Read More
Arcturus Therapeutics/CSL Partnered COVID-19 Vaccine Surpasses Pfizer's Comirnaty Shot, Even At Lower Doses
Via Benzinga
Exposures COVID-19
Is Summit Therapeutics Stock a Buy?
Via The Motley Fool
15 Best Dividend Stocks for Lifelong Passive Income
Via The Motley Fool
Pfizer Unusual Options Activity
Via Benzinga
Current Report: Pfizer (PFE)
Via Talk Markets
3 Surprisingly Underrated Stocks to Buy Right Now
Via The Motley Fool
Pfizer Voluntarily Withdraws Sickle Cell Disease Treatment Oxbryta From Global Market Due To Painful Disease Complication, Deaths
Via Benzinga
Pfizer Tanked A $5.4 Billion Takeover. Why Crispr, Agios, Beam Could Benefit.
Via Investor's Business Daily
2 High-Yield Dividend Stocks That Can Deliver a Lifetime of Passive Income
Via The Motley Fool
3 Ultra-High-Yield Dividend Stocks to Buy Now and Hold at Least a Decade
Via The Motley Fool
Pfizer Voluntarily Withdraws All Lots of Sickle Cell Disease Treatment OXBRYTA® (voxelotor) From Worldwide Markets
From Pfizer Inc.
Via Business Wire
1 Ultra-High-Yield Healthcare Stock to Buy Hand Over Fist and 1 to Avoid
Via The Motley Fool
3 Ultra-Cheap Stocks That Could Get a Boost From Fed Rate Cuts
Via The Motley Fool
Topics Economy
Exposures Interest Rates
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Ideaya Biosciences Stock Tumbles Despite Promising Data From Rare Eye Cancer Candidate
Via Benzinga
2 Beaten-Down Stocks to Buy and Hold for a Decade
Via The Motley Fool
Novo Nordisk, Chewy And FedEx Are Among Top 10 Large Cap Losers Last Week (Sept 15-Sept 21): Are The Others In Your Portfolio?
Via Benzinga
3 Dirt Cheap Stocks to Buy Right Now
Via The Motley Fool
Pfizer Advances On Its Cancer Journey
Via Benzinga
Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 3% Dividend Yields
Via Benzinga
How Critical Demand for Metastatic Breast Cancer Therapies is Producing a Multi-Billion Dollar Opportunity for Biotechs
Via FinancialNewsMedia
Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron KP.2-adapted COVID-19 Vaccine in the European Union
From Pfizer Inc.
Via Business Wire
How Critical Demand for Metastatic Breast Cancer Therapies is Producing a Multi-Billion Dollar Opportunity for Biotechs
From FN Media Group LLC
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.

Never miss important news. Subscribe to our newsletter.
Register for free

Information

Copyright 2024. BUSINESS INSURANCE HOLDINGS